VPIM
BNGO icon

Vanguard Personalized Indexing Management’s Bionano Genomics BNGO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-225
Closed -$6.14K – 1821
2024
Q3 		$6.14K Sell
225
-258
-53% -$8.03K ﹤0.01% 1768
2024
Q2 		$19.6K Buy
+483
New +$26.5K ﹤0.01% 1651

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Personalized Indexing Management's BNGO Position: Q4 2024 in Review

Vanguard Personalized Indexing Management sold out of Bionano Genomics (BNGO) in Q4 2024, closing a stake of 225 shares — an estimated $6.14K sold.

Vanguard Personalized Indexing Management first reported a position in BNGO in Q2 2024 and held it in 2 quarters. The position peaked at $19.6K in Q2 2024. 50 funds tracked by Wall St. Rank hold BNGO as of Q4 2024.

  • Vanguard Personalized Indexing Management reported no remaining Bionano Genomics position as of Q4 2024 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 225 Bionano Genomics shares in Q4 2024, an estimated $6.14K.
  • Vanguard Personalized Indexing Management first reported a position in Bionano Genomics in Q2 2024 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Bionano Genomics position peaked at $19.6K in Q2 2024.
  • 50 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2024, filed 10 Feb 2025.